坦索罗辛在较大输尿管下段结石ESWL后辅助排石的疗效观察
 |
| 第1页 |
参见附件(2250KB，2页)。
4 结论
应用高选择性α1A/D肾上腺素能受体抗结剂坦索罗辛(每日0.4 mg)，可以显著提高ESWL治疗较大输尿管下段结石的成功率及治疗效率。在4周的临床应用中不良反应轻微。而且坦索罗辛结合保守治疗可以减轻ESWL术后结石碎片引起的绞痛。因此，建议在ESWL治疗较大(10 mm以上)输尿管下段结石的过程中，应用坦索罗辛作为ESWL术后辅助治疗。
参考文献
[1]Kupeli B, Irkilata L, Gurocak S D, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?Urology,2004,64:1111-1115.
[2]Resim S, Ekerbicer H C, Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy.Urology,2005,66:945-948.
[3]Dellabella M, Milanese G. Muzzonigro G Randomized trial of the efficacy of tamsulosin,nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi.J Urol,2005,174:167-172.
[4]Autorino R, Desio M, Damiano R, et al. The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?Urol Res,2005,33:460-464.
[5]Bhagat S K, Chacko N K,Kekre N S, et al. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi?J Urol,2007,177:2185-2188.
[6]Agarwal M M, Naja V, Singh S K, et al. Is there an adjunctive role of tamsulosin to extracorporeal shockwave lithotripsy for upper ureteric stones: results of an open label randomized nonplacebo controlled study.Urology,2009,74:989-993.
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(2250KB，2页)。